Sustained biochemical engraftment and early clinical outcomes following ex-vivo autologous stem cell gene therapy for mucopolysaccharidosis type IIIA

被引：2
|
作者：
Jones, Simon [1 ]
Kinsella, Jane [2 ]
Holley, Rebecca [3 ]
Potter, Jane [2 ]
Booth, Claire [4 ]
Buckland, Karen [4 ]
Rust, Stewart [5 ]
Church, Heather J. [6 ]
Brammeier, Kathryn L. [7 ]
Lee, Helena [8 ]
Ford, Laura [8 ]
Ellison, Stuart M. [9 ]
Bigger, Brian [3 ]
Wynn, Robert [10 ]
机构：
[1] St Marys Hosp, Manchester, Lancs, England
[2] Royal Manchester Childrens Hosp, Manchester, Lancs, England
[3] Univ Manchester, Manchester, Lancs, England
[4] UCL, Inst Child Hlth, London, England
[5] Royal Manchester Childrens Hosp, Paediat Neuropsychol, Manchester, Lancs, England
[6] Manchester Univ NHS Fdn Trust, St Marys Hosp, Willink Biochem Genet Unit, Manchester Ctr Genom Med, Manchester, Lancs, England
[7] Manchester Univ NHS Fdn Trust, Manchester Ctr Genom Med, Manchester, Lancs, England
[8] St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England
[9] Univ Manchester, Stemcell & Neurotherapies Grp, Manchester, Lancs, England
[10] Royal Manchester Childrens Hosp, Bone Marrow Transplantat Unit, Manchester, Lancs, England
来源：
MOLECULAR GENETICS AND METABOLISM | 2023年 / 138卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2022.107171
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
188
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [31] Pre-clinical development of an ex-vivo lentiviral-based Hematopoietic Stem/Progenitor Cells (HSPC)-gene therapy (GT) approach for Mucopolysaccharidosis type IVA (MPSIVA)
    Crippa, S.
    Quaranta, P.
    Berti, M.
    Santi, L.
    De Ponti, G.
    Jofra-Hernandez, R.
    Basso-Ricci, L.
    Rilievo, A. A.
    Alberti, G.
    Forni, C.
    Visigalli, I.
    Albertini, P.
    Paoli, A.
    Morrone, A.
    Parini, R.
    Gentner, B.
    Scala, S.
    Aiuti, A.
    Bernardo, M. E.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A170 - A171
  • [32] Ex vivo stem cell gene therapy of the skin Ready for clinical use?
    Koller, Ulrich
    HAUTARZT, 2020, 71 (02): : 85 - 90
  • [33] Interim Analysis on Neurological Outcomes in Hurler Syndrome Patients Treated with Autologous Ex Vivo Hematopoietic Stem Cell Gene Therapy
    Consiglieri, Giulia
    Fumagalli, Francesca
    Tucci, Francesca
    Filisetti, Chiara
    Cossutta, Matilde
    Scarparo, Stefano
    Sarzana, Marina
    Puricelli, Cristina
    Ciotti, Francesca
    Barbera, Maurizio
    Darin, Silvia
    Parini, Rossella
    Baldoli, Cristina
    Gentner, Bernhard Rudolf
    Aiuti, Alessandro
    Bernardo, Maria Ester
    MOLECULAR THERAPY, 2024, 32 (04) : 885 - 886
  • [34] Outcomes of penetrating keratoplasty following ex vivo expanded autologous limbal stem cell transplantation (ALSCT)
    Figueiredo, Francisco C.
    Baylis, Oliver
    Salvador-Culla, Borja
    Lako, Majlinda
    Figueiredo, Gustavo S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [35] Sustained LCAT replacement in patient with familial LCAT deficiency in clinical trial of ex vivo gene/cell therapy using autologous preadipocytes
    Kuroda, M.
    Aso, M.
    Yamamoto, T. T.
    Wada, J.
    Ishikawa, K.
    Maezawa, Y.
    Teramoto, N.
    Kubota, Y.
    Tawada, A.
    Aoyagi, Y.
    Asada, S.
    Kirinashizawa, M.
    Onitake, A.
    Matsuura, Y.
    Yasunaga, K.
    Konnno, S.
    Nishino, K.
    Yamamoto, M.
    Miyoshi, J.
    Kobayashi, N.
    Tanio, M.
    Ikeuchi, T.
    Igari, H.
    Mitsukawa, N.
    Hanaoka, H.
    Saito, Y.
    Yokote, K.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A20 - A20
  • [36] Ex vivo lentiviral gene transfer targeting hematopoietic stem cells for therapy of mucopolysaccharidosis type II, Hunter syndrome
    McIvor, R. Scott
    Wolf, Daniel A.
    Podetz-Petersen, Kelly
    Nan, Zhenhong
    Whitley, Chester B.
    Muenzer, Joseph
    Orchard, Paul J.
    Low, Walter C.
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S30 - S31
  • [37] Mucopolysaccharidosis Type I Ex Vivo Gene Therapy Based on MLV-Mesenchymal Stem Cell Transduction: Is There a Way To Be Attenuated When Older?
    Silva, Flavia H.
    Pereira, Vanessa F.
    Yasumura, Eduardo
    Tenorio, Ligia Z.
    Carvalho, Leonardo P.
    Lisboa, Bianca C.
    Calegare, Bruno F.
    Brandao, Leticia D.
    D'Almeida, Vania
    Filippo, Thais R.
    Porcionatto, Marimelia
    Toma, Leny
    Nader, Helena B.
    Camassola, Melissa
    Nardi, Nance B.
    Han, Sang W.
    MOLECULAR THERAPY, 2009, 17 : S345 - S345
  • [38] Ex-Vivo Expanded NK Cell Therapy Combined with Elotuzumab for MRD after Autologous Stem Cell Transplantation: A Phase I/II Clinical Trial in Progress
    Hagiwara, Shotaro
    Wang, Yan-Hua
    Kobayashi, Hirohito
    Kato, Yutaka
    Tanaka, Norina
    Iizuka, Yuki
    Watanabe, Aya
    Ishiyama, Midori
    Shinohara, Akihito
    Kazama, Hiroshi
    Yoshinaga, Kentaro
    Shiseki, Masayuki
    Kanno, Hitoshi
    Tanaka, Junji
    BLOOD, 2019, 134
  • [39] A GLB1 transgene with enhanced therapeutic potential for the preclinical development of ex-vivo gene therapy to treat mucopolysaccharidosis type IVB
    Crippa, Stefania
    Alberti, Gaia
    Passerini, Laura
    Savoia, Evelyn Oliva
    Mancino, Marilena
    De Ponti, Giada
    Santi, Ludovica
    Berti, Margherita
    Testa, Marialuisa
    Hernandez, Raisa Jofra
    Quaranta, Pamela
    Ceriotti, Selene
    Visigalli, Ilaria
    Morrone, Amelia
    Paoli, Antonella
    Forni, Claudia
    Scala, Serena
    Degano, Massimo
    Staiano, Leopoldo
    Gregori, Silvia
    Aiuti, Alessandro
    Bernardo, Maria Ester
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (03)
  • [40] Hematopoietic stem cell gene therapy for the treatment of Type I Mucopolysaccharidosis: towards clinical application
    Visigalli, I.
    Delai, S.
    Ferro, F.
    Cecere, F.
    Sanvito, F.
    Cristofori, P.
    Naldini, L.
    Biffi, A.
    HUMAN GENE THERAPY, 2013, 24 (12) : A133 - A134
12345